TY  - JOUR

T1  - Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study

JO  - American Journal of Clinical Dermatology

UR  - http://dx.doi.org/10.1007/s40257-024-00859-y

PY  - 2024/05/14

AU  - Paller AS

AU  - Siegfried EC

AU  - Simpson EL

AU  - Cork MJ

AU  - Sidbury R

AU  - Chen IH

AU  - Khokhar FA

AU  - Xiao J

AU  - Dubost-Brama A

AU  - Bansal A

ED  - 

DO  - DOI: 10.1007/s40257-024-00859-y

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/22

ER  -